# Project BEST: Buprenorphine Entry Into Substance Abuse Treatment

> **NCT02583243** · — · COMPLETED · sponsor: **Yale University** · enrollment: 209 (actual)

## Conditions studied

- Opioid-related Disorders
- HIV Infections
- Hepatitis C, Chronic
- Depression

## Interventions

- **BEHAVIORAL:** MET/CBT based individualized counseling
- **DRUG:** Buprenorphine

## Key facts

- **NCT ID:** NCT02583243
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 209 (ACTUAL)
- **Last updated:** 2020-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02583243

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02583243, "Project BEST: Buprenorphine Entry Into Substance Abuse Treatment". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02583243. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*